197 related articles for article (PubMed ID: 22146489)
1. IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity.
Doyle SL; Donohoe CL; Finn SP; Howard JM; Lithander FE; Reynolds JV; Pidgeon GP; Lysaght J
Am J Gastroenterol; 2012 Feb; 107(2):196-204. PubMed ID: 22146489
[TBL] [Abstract][Full Text] [Related]
2. Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma.
Donohoe CL; Doyle SL; McGarrigle S; Cathcart MC; Daly E; O'Grady A; Lysaght J; Pidgeon GP; Reynolds JV
Br J Surg; 2012 Mar; 99(3):387-96. PubMed ID: 22241325
[TBL] [Abstract][Full Text] [Related]
3. [Expression of IGF-1R in esophageal squamous cell carcinoma and the effect of its silencing by siRNA on the proliferation of esophageal cancer EC9706 cells in vitro].
Ma W; Li W; Fan QX; Wang LX; Wang RL; Lu SX
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):609-12. PubMed ID: 22325222
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
Kalinina T; Bockhorn M; Kaifi JT; Thieltges S; Güngör C; Effenberger KE; Strelow A; Reichelt U; Sauter G; Pantel K; Izbicki JR; Yekebas EF
Int J Cancer; 2010 Oct; 127(8):1931-40. PubMed ID: 20104520
[TBL] [Abstract][Full Text] [Related]
5. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor type I receptor gene expression and obesity in esophageal adenocarcinoma.
Zhao R; Macdonald K; Casson AG
Mol Carcinog; 2009 Nov; 48(11):982-8. PubMed ID: 19582762
[TBL] [Abstract][Full Text] [Related]
7. Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.
Verbeke H; De Hertogh G; Li S; Vandercappellen J; Noppen S; Schutyser E; El-Asrar AA; Opdenakker G; Van Damme J; Geboes K; Struyf S
Hum Pathol; 2010 Jul; 41(7):990-1001. PubMed ID: 20334899
[TBL] [Abstract][Full Text] [Related]
8. Absence or low IGF-1R-expression in esophageal adenocarcinoma is associated with tumor invasiveness and radicality of surgical resection.
De Bruijn K; Biermann K; Shapiro J; Dogan F; Spaander M; Janssen J; Wijnhoven B; Borsboom G; Hofland L; van Eijck C
J Surg Oncol; 2015 Jun; 111(8):1047-53. PubMed ID: 26082409
[TBL] [Abstract][Full Text] [Related]
9. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
10. A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma.
MacDonald K; Porter GA; Guernsey DL; Zhao R; Casson AG
Cancer Epidemiol; 2009 Jul; 33(1):37-40. PubMed ID: 19679045
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of IGF-2 and IGF-1 receptor expression in oral cancer cell lines.
Brady G; Crean SJ; Naik P; Kapas S
Int J Oncol; 2007 Oct; 31(4):875-81. PubMed ID: 17786320
[TBL] [Abstract][Full Text] [Related]
12. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of nerve growth factor in poorly differentiated and advanced human esophageal cancer.
Zhu ZW; Friess H; Wang L; Di Mola FF; Zimmermann A; Büchler MW
Anticancer Res; 2000; 20(1A):125-32. PubMed ID: 10769644
[TBL] [Abstract][Full Text] [Related]
14. Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus.
Tihan T; Harmon JW; Wan X; Younes Z; Nass P; Duncan KL; Duncan MD
Anticancer Res; 2001; 21(4B):3107-14. PubMed ID: 11712819
[TBL] [Abstract][Full Text] [Related]
15. STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas.
Timme S; Ihde S; Fichter CD; Waehle V; Bogatyreva L; Atanasov K; Kohler I; Schöpflin A; Geddert H; Faller G; Klimstra D; Tang L; Reinheckel T; Hauschke D; Busch H; Boerries M; Werner M; Lassmann S
Oncogene; 2014 Jun; 33(25):3256-66. PubMed ID: 23912451
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
17. Serum IGF-1 linking visceral obesity with esophageal adenocarcinoma: unconvincing evidence.
McColl KE
Am J Gastroenterol; 2012 Feb; 107(2):205-6. PubMed ID: 22306944
[TBL] [Abstract][Full Text] [Related]
18. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
[TBL] [Abstract][Full Text] [Related]
19. Expression of IGF-1 and IGF-1R and their relation to clinicopathological factors in colorectal cancer.
Shiratsuchi I; Akagi Y; Kawahara A; Kinugasa T; Romeo K; Yoshida T; Ryu Y; Gotanda Y; Kage M; Shirouzu K
Anticancer Res; 2011 Jul; 31(7):2541-5. PubMed ID: 21873172
[TBL] [Abstract][Full Text] [Related]
20. Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China.
Goscinski MA; Suo ZH; Nesland JM; Chen WT; Zakrzewska M; Wang J; Zhang S; Flørenes VA; Giercksky KE
Oncology; 2008; 75(1-2):49-59. PubMed ID: 18787344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
